<DOC>
	<DOCNO>NCT01028508</DOCNO>
	<brief_summary>This study determine whether medication alone medication electroconvulsive therapy ( ECT ) work best prevent depressive relapse improve quality life old people severe mood disorder .</brief_summary>
	<brief_title>Prolonging Remission Depressed Elderly ( PRIDE )</brief_title>
	<detailed_description>While advance make acute treatment geriatric depression , failure maintain remission follow successful treatment remain major public health problem . In particular , loss antidepressant response result ongoing functional impairment increase risk suicide . This especially salient severe and/or treatment resistant illness , even successful ECT . This trial build upon work Consortium Research Electroconvulsive Therapy ( CORE ) group show continuation ECT combination pharmacotherapy equally effective prevent relapse follow response acute ECT . We test whether combine pharmacotherapy ECT , individualize accord patient response , effective maintain remission depress old adult pharmacotherapy alone . Moving beyond traditional fixed schedule continuation ECT , introduce novel Symptom-Titrated Algorithm-Based Longitudinal ECT ( STABLE ) regimen . The STABLE algorithm ensure time ECT treatment base upon clinical need , help achieve dual goal adequately treat people show early sign symptom re-emergence , prevent over-treatment patient may stable remission . The continuation therapy `` usual care '' comparator arm combination pharmacotherapy Li plus VLF ( PHARM ) . At 7 site , 322 patient receive acute course right unilateral ( RUL ) ECT augment standardized medication ( Phase I ) ; 188 remitters randomly assign one 2 group follow 6 month ( Phase II ) . To balance amount clinical contact , schedule clinic telephone rating identical patient PHARM STABLE arm . For group , relapse define Hamilton Rating Scale Depression-24 ( HRSD24 ) score &gt; 21 two consecutive time point , suicidality , psychiatric hospitalization .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>DSMIV diagnosis major depressive episode , unipolar , base MiniInternational Neuropsychiatric Interview ( M.I.N.I ) DSMIV ECT clinically indicate Lifetime history bipolar affective disorder , schizophrenia , schizoaffective disorder , mental retardation Current diagnosis delirium , dementia , substance abuse/dependence past 6 month define DSMIVTR criterion</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Depression</keyword>
	<keyword>ECT</keyword>
	<keyword>electroconvulsive therapy</keyword>
	<keyword>mood disorder</keyword>
	<keyword>continuation ECT</keyword>
	<keyword>continuation pharmacotherapy</keyword>
	<keyword>geriatric</keyword>
	<keyword>elderly</keyword>
	<keyword>lithium</keyword>
	<keyword>venlafaxine</keyword>
</DOC>